A subclone of the IPC leukemia cells expressing the prosurvival oncogenic protein Bcl-2 is resistant towards several apoptotic stimuli [10,11], including current anti-leukemic chemotherapy drugs like the anthracycline. The gene discussed is BCL2; the disease is leukemia.